Mirabaud Asset Management »

Cytokinetics shares owned by Mirabaud Asset Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Mirabaud Asset Management from 13F filings

Historical chart of Mirabaud Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Mirabaud Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Mirabaud Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.1B 4.6M 1761.74

More positions owned by Mirabaud Asset Management

Lci Inds Note 3.000% 3/0 (Principal)
Upstart Hldgs Note 2.000%10/0 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Nutanix Note 0.250%10/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Irhythm Holdings Note 1.500% 9/0 (Principal)
Nextera Energy Cap Hldgs Note 3.000% 3/0 (Principal)
Liberty Media Corp Del Note 2.250% 8/1 (Principal)
Akamai Technologies Note 1.125% 2/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Snowflake Note 10/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Unity Software Note 3/1 (Principal)
Strategy Note 2.250% 6/1 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)

View all positions for Mirabaud Asset Management

Top funds holding Cytokinetics

Balyasny Asset Management
Two Sigma Investments
Lazard Asset Management
Nuveen
Bank of America Corporation
Capstone Investment Advisors
Mirabaud Asset Management
Leucadia National Corporation
Wellington Management Company
Wolverine Asset Management
Goldman Sachs Group
Morgan Stanley
Bnp Paribas Investment Partners
FMR
Context Capital Management

View all funds holding Cytokinetics